Maron Samuel Z, Cedillo Mario A, Sher Alex, Kim Jeremy, Fischman Aaron M
Department of Radiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York.
Charlotte Radiology, Charlotte, North Carolina.
J Vasc Interv Radiol. 2020 Jul;31(7):1084-1089. doi: 10.1016/j.jvir.2020.02.029. Epub 2020 May 23.
This retrospective report describes treatment of 21 patients who underwent prostatic artery embolization using 70- to 150-μm radiopaque microspheres for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Seventeen patients (81%) received successful bilateral prostatic artery embolization. At a mean follow-up of 42 days (range, 25-59 days), patients showed improvement in International Prostate Symptom Score (n = 11; mean = 10.6; P = .001), quality of life score (n = 17; mean = 2.0; P = .02), and International Index of Erectile Function (n = 17; mean = 9.3; P = .01). The mean prostate volume reduction was 28 mL (16.2%; P = .003). Nontarget embolization occurred twice, resulting in 1 minor adverse event of hematospermia.
本回顾性报告描述了21例因良性前列腺增生继发下尿路症状而接受前列腺动脉栓塞术的患者的治疗情况，这些患者使用70至150微米的不透射线微球进行栓塞。17例患者（81%）成功进行了双侧前列腺动脉栓塞。平均随访42天（范围25至59天），患者的国际前列腺症状评分（n = 11；平均值 = 10.6；P = .001）、生活质量评分（n = 17；平均值 = 2.0；P = .02）和国际勃起功能指数（n = 17；平均值 = 9.3；P = .01）均有所改善。前列腺体积平均减少28 mL（16.2%；P = .003）。发生了2次非靶栓塞，导致1例轻度血精不良事件。
